March 11, 2025 - 11:22

Geneva, Switzerland, March 11, 2025 — SEALSQ Corp, a leader in semiconductors and post-quantum technology, has announced a groundbreaking partnership with ColibriTD to launch a Quantum Cloud Computing as a Service (QaaS). This innovative service aims to democratize access to quantum computing solutions for enterprises and research institutions, enabling them to harness the power of quantum technology without the need for significant upfront investments in hardware.
The QaaS platform will provide users with the ability to run complex computations and simulations that were previously unfeasible with classical computing methods. This service is expected to accelerate advancements in various fields such as cryptography, materials science, and artificial intelligence. By offering a cloud-based model, SEALSQ and ColibriTD are making it easier for organizations of all sizes to explore and implement quantum solutions, fostering innovation and collaboration in the rapidly evolving tech landscape.
With this launch, both companies are poised to play a pivotal role in shaping the future of quantum computing, making cutting-edge technology accessible to a broader audience.
May 9, 2026 - 22:04
Compass Diversified Q1 Earnings Call HighlightsCompass Diversified, the publicly traded holding company known as CODI, reported its first-quarter 2026 earnings this week, with management framing the period as one of disciplined execution. Chief...
May 9, 2026 - 00:34
Urbana Corporation Has Filed 2026 First Quarter Interim Financial StatementsTORONTO - Urbana Corporation has submitted its unaudited interim financial statements and management discussion for the first quarter of 2026. The filing covers the three-month period ending March...
May 8, 2026 - 11:59
Australia regulator calls for urgent cybersecurity action to counter MythosAustralia`s corporate watchdog has called on the country`s financial industry to take urgent steps to address cybersecurity risks posed by advanced artificial intelligence systems, including a...
May 7, 2026 - 20:22
IN8bio Reports First Quarter 2026 Financial Results and Recent Business HighlightsIN8bio, a clinical-stage biopharmaceutical company focused on gamma-delta T cell therapies, announced its financial results for the first quarter of 2026 along with key business updates. The...